Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Betaxolol manufacturers

Filters

Filters

Filters , active

Country of origin : India

Clear all

None products found

betaxolol

Ophthalmic solution 0.5 % - 5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #31072

This pharmaceutical company is a niche player specializing in ophthalmic, inhalational (for nebulization), otic, and nasal drop products since its founding in 1990. The company focuses on developing both generic and innovative products across therapy areas such as eye care and specialty medications. Its manufacturing facilities emphasize "Best Quality, On Time, Every Time," adhering to strict GMP certifications. While specific regions aren't mentioned, the company highlights a global reach with over 150 highly skilled employees. The firm boasts a diverse product portfolio exceeding 20 products and holds several patents related to its offerings.

betaxolol

Eye drops 0.5 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #17331
This company has been operating in the pharmaceutical industry for over five decades, demonstrating a strong commitment to healthcare solutions. They specialize in manufacturing finished dosage formulations, biosimilars, and API/DC granules, catering to diverse needs within the healthcare market. Their focus on research and development drives innovation and ensures high-quality products, while their commitment to regulatory compliance ensures patient safety and efficacy. They possess extensive experience in the pharmaceutical industry, with a global reach and a strong presence in key regions like Asia and North America. Their production lines are compliant with EU and US GMP standards, reflecting their dedication to quality and adherence to international best practices. Key therapy areas include oncology, cardiology, and other areas where biosimilars are widely used. They offer a variety of dosage forms including solids, liquids, and injectables. While specific product patents are not explicitly mentioned, their focus on innovation and research suggests they actively pursue intellectual property protection for their offerings.

betaxolol

Eye drops 0.25 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19639

This globally operating pharmaceutical company focuses on developing and manufacturing a broad range of affordable medications. They specialize in both prescription and over-the-counter drugs, including oncology treatments, antibacterials, injectables (both specialty and large volume), ophthalmic products, dermatological preparations, and veterinary pharmaceuticals. Their product portfolio also includes unique niche drugs and orphan products, showcasing their commitment to addressing diverse medical needs. The company boasts state-of-the-art manufacturing facilities located across several regions, adhering to strict quality standards recognized by international regulatory bodies like the WHO GMP, US FDA, and MCC. Their extensive global reach spans over 45 countries in Asia, Africa, Latin America, CIS, Europe, Australia, and the Pacific Ocean. The company's focus on research and development, coupled with its global manufacturing capabilities and commitment to quality, positions them as a key player in the international pharmaceutical market.

Manufacturer usually replies in 22 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.